Merck says COVID-19 pill cuts risks in half, will seek emergency authorization | TheHill: Pharmaceutical company Merck on Friday said it will seek an emergency authorization for its oral antiviral COVID-19 treatment after the medicine was shown to reduce the risk of hospitalization by 50 percent during clinical trials.
No comments:
Post a Comment